Primary Site >> Colorectal Cancer
Gene >> PTPRU
| 1. | |||||||||||
| Journal: | Am J Clin Oncol. 1987 Aug;10(4):320-4. | ||||||||||
| Title: | A randomized clinical trial of combination chemotherapy in advanced colorectal cancer. | ||||||||||
| Author: | O'Connell, M J|Schutt, A J|Moertel, C G|Rubin, J|Hahn, R G|Scott, M | ||||||||||
| PMID: | 3303905 | ||||||||||
| 2. | |||||||||||
| Journal: | Br J Cancer. 1995 Nov;72(5):1083-8. | ||||||||||
| Title: | Anti-tumour effects of an antibody-carboxypeptidase G2 conjugate in combination with phenol mustard prodrugs. | ||||||||||
| Author: | Blakey, D C|Davies, D H|Dowell, R I|East, S J|Burke, P J|Sharma, S K|Springer, C J|Mauger, A B|Melton, R G | ||||||||||
| PMID: | 7577451 | ||||||||||
| 3. | |||||||||||
| Journal: | Cancer Lett. 1995 Jul 13;93(2):239-48. | ||||||||||
| Title: | Increased mRNA expression of the receptor-like protein tyrosine phosphatase alpha in late stage colon carcinomas. | ||||||||||
| Author: | Tabiti, K|Smith, D R|Goh, H S|Pallen, C J | ||||||||||
| PMID: | 7621435 | ||||||||||
| 4. | |||||||||||
| Journal: | Anticancer Res. 1996 Mar-Apr;16(2):943-6. | ||||||||||
| Title: | Histochemically demonstrable protein tyrosine phosphatase in human breast and colorectal cancer: large decrease in its activity in colorectal cancer suggests a tumor suppressor role in colorectal mucosal cells. | ||||||||||
| Author: | Partanen, S | ||||||||||
| PMID: | 8687156 | ||||||||||
| 5. | |||||||||||
| Journal: | Exp Cell Res. 1998 May 1;240(2):236-43. | ||||||||||
| Title: | Elevated expression of the cdc25A protein phosphatase in colon cancer. | ||||||||||
| Author: | Dixon, D|Moyana, T|King, M J | ||||||||||
| PMID: | 9596996 | ||||||||||
| 6. | |||||||||||
| Journal: | J Biol Chem. 2005 Mar 4;280(9):8180-7. Epub 2004 Dec 20. | ||||||||||
| Title: | Crystal structure of the PTPL1/FAP-1 human tyrosine phosphatase mutated in colorectal cancer: evidence for a second phosphotyrosine substrate recognition pocket. | ||||||||||
| Author: | Villa, Fabrizio|Deak, Maria|Bloomberg, Graham B|Alessi, Dario R|van Aalten, Daan M F | ||||||||||
| PMID: | 15611135 | ||||||||||
| 7. | |||||||||||
| Journal: | Cell Death Differ. 2006 Feb;13(2):202-11. | ||||||||||
| Title: | Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells. | ||||||||||
| Author: | Monteleone, G|Franchi, L|Fina, D|Caruso, R|Vavassori, P|Monteleone, I|Calabrese, E|Naccari, G C|Bellinvia, S|Testi, R|Pallone, F | ||||||||||
| PMID: | 16082388 | ||||||||||
| 8. | |||||||||||
| Journal: | J Biol Chem. 2006 Jun 2;281(22):15423-33. Epub 2006 Mar 30. | ||||||||||
| Title: | Protein-tyrosine phosphatase PCP-2 inhibits beta-catenin signaling and increases E-cadherin-dependent cell adhesion. | ||||||||||
| Author: | Yan, He-Xin|Yang, Wen|Zhang, Rui|Chen, Lei|Tang, Liang|Zhai, Bo|Liu, Shu-Qin|Cao, Hui-Fang|Man, Xiao-Bo|Wu, Hong-Ping|Wu, Meng-Chao|Wang, Hong-Yang | ||||||||||
| PMID: | 16574648 | ||||||||||
| 9. | |||||||||||
| Journal: | Oncogene. 2006 Oct 12;25(47):6319-24. | ||||||||||
| Title: | DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. | ||||||||||
| Author: | Balavenkatraman, K K|Jandt, E|Friedrich, K|Kautenburger, T|Pool-Zobel, B L|Ostman, A|Bohmer, F D | ||||||||||
| PMID: | 16682945 | ||||||||||
| 10. | |||||||||||
| Journal: | Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4060-4. Epub 2007 Feb 21. | ||||||||||
| Title: | Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. | ||||||||||
| Author: | Zhang, Xiaodong|Guo, Ailan|Yu, Jianshi|Possemato, Anthony|Chen, Yueting|Zheng, Weiping|Polakiewicz, Roberto D|Kinzler, Kenneth W|Vogelstein, Bert|Velculescu, Victor E|Wang, Zhenghe John | ||||||||||
| PMID: | 17360477 | ||||||||||
| 11. | |||||||||||
| Journal: | Oncotarget. 2011 Dec;2(12):1155-64. | ||||||||||
| Title: | Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects. | ||||||||||
| Author: | Yi, Taolin|Elson, Paul|Mitsuhashi, Masato|Jacobs, Barbara|Hollovary, Emese|Budd, Thomas G|Spiro, Timothy|Triozzi, Pierre|Borden, Ernest C | ||||||||||
| PMID: | 22201704 | ||||||||||
| 12. | |||||||||||
| Journal: | Cancer Biol Ther. 2018 Jul 23:1-4. | ||||||||||
| Title: | Unusually long-term responses to vemurafenib in BRAF V600E mutated colon and thyroid cancers followed by the development of rare RAS activating mutations. | ||||||||||
| Author: | Ofir Dovrat, Tali|Sokol, Ethan|Frampton, Garrett|Shachar, Eliya|Pelles, Sharon|Geva, Ravit|Wolf, Ido | ||||||||||
| PMID: | 30036146 | ||||||||||